Citations

Showing 10 of 108094 citations.

Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse
Zattoni, Fabio , Morlacco, Alessandro , Nehra, Avinash , Frank, Igor, Boorjian, Stephen A. , Thapa, Prabin , Karnes, R. Jeffrey , Zattoni, Fabio

Mayo Clinic

International braz j urol | July 4, 2018 | Volume: 44 | Issue: 3 | Pages: 491-499

10.1590/s1677-5538.ibju.2017.0376 | PMID 29244270 Get It

Development and Preliminary Findings of the Dizziness Symptom Profile
Jacobson, Gary P. , Piker, Erin G. , Hatton, Kelsey, Watford, Kenneth E. , Trone, Timothy , McCaslin, Devin L. , Bennett, Marc , Haynes, David S. , Roberts, Richard A. , Rivas, Alejandro

Mayo Clinic

Ear & Hearing | July 4, 2018 | Volume: 40 | Issue: 3 | Pages: 568-576

10.1097/aud.0000000000000628 | PMID 29979254 Get It

Objectives: Dizziness, vertigo, and unsteadiness are common complaints of patients who present to primary care providers. These patients often are referred to otology for assessment and management. Unfortunately, there are a small number of specialists to manage these patients. However, there are several dizziness disorders that can be successfully managed by primary care providers if the disorder is properly identified. To assist in the identification of several of the most common dizziness disorders, we developed the dizziness symptom profile (DSP). The DSP is a self-report questionnaire designed to generate one or more differential diagnoses that can be combined with the patient’s case history and physical examination. Design: This report describes three investigations. Investigations 1 and 2 (i.e., exploratory and confirmatory investigations, N = 514) describe the development of the DSP. Investigation 3 (N = 195) is a validation study that describes the level of agreement between the DSP completed by the patient, and, the differential diagnosis of the otologist. Results: The final version of the DSP consists of 31 items. Preliminary findings suggest that the DSP is in agreement with the differential diagnoses of ear specialists for Meniere’s disease (100% agreement), vestibular migraine (95% agreement), and benign paroxysmal positional vertigo (82% agreement). Conclusions: Early results suggest that DSP may be useful in the creation of differential diagnoses for dizzy patients that can be evaluated and managed locally. This has the potential to reduce the burden on primary care providers and reduce delays in the diagnosis of common dizziness and vertigo disorders.
Goniotomy Using the Kahook Dual Blade in Severe and Refractory Glaucoma: 6-Month Outcomes
Salinas, Lauriane, Chaudhary, Ankita, Lazcano-Gómez, Gabriel , Williamson, Blake K. , Dorairaj, Syril , Seibold, Leonard K., Smith, Sanjay, Aref, Ahmad A. , Darlington, Jason K., Jiménez-Román, Jesús, Mahootchi, Ahad , Boucékine, Mohamed , Mansouri, Kaweh , Dorairaj, Syril K., Berdahl, John Palmer

Mayo Clinic

Journal of Glaucoma | July 4, 2018 | Volume: 27 | Issue: 10 | Pages: 849-855

10.1097/ijg.0000000000001019 | PMID 29979337 Get It

Purpose: The purpose of the study is to describe short-term efficacy and safety of goniotomy with trabecular meshwork excision using the Kahook Dual Blade (KDB, New World Medical Inc., Rancho Cucamonga, CA) in patients with severe or refractory glaucoma. Method: Retrospective multicentric case series of 53 eyes with severe or refractory glaucoma as defined by ICD-10 conducted in the United States, Mexico, and Switzerland. Primary efficacy outcome was a ≥20% decrease in intraocular pressure (IOP) from baseline at 6 months. Secondary efficacy outcome measures were probability of achieving an IOP≤14 or 18 mm Hg at 6 months and the mean IOP change from baseline at 6 months. Medication use required to obtain target IOP at last follow up and adverse effects were analyzed. Results: The proportion of eyes achieving an IOP reduction of >20% from preoperative baseline at 6 months was 57.7% (n=30). The mean IOP decreased from 18.4±6.1 mm Hg at baseline to 13.9±3.5 mm Hg at month 6 (23.9% reduction; P<0.001). At 6 months, 63.5% and 92.3% achieved an IOP≤14 and ≤18 mm Hg, respectively, and the mean number of glaucoma medications was reduced by 1.2±1.3 (36.6%) compared with baseline (P<0.001). The most common adverse event was hyphema (n=29, 34.9%) with spontaneous resolution in all cases. No severe complications were reported. One case presented with uncontrolled IOP and required glaucoma drainage device surgery at 1 month. Conclusions: Goniotomy with trabecular meshwork excision using the KDB could be an alternative surgery for severe or refractory glaucoma, significantly reducing IOP and medication use at 6 months, with a low rate of complications.
Uridine triacetate for severe 5-fluorouracil toxicity in a patient with thymidylate synthase gene variation: Potential pharmacogenomic implications
Baldeo, Candice , Mody, Kabir , Kasi, Pashtoon Murtaza , Vishnu, Prakash , Kasi, Pashtoon Murtaza

Mayo Clinic

SAGE Open Medical Case Reports | July 4, 2018 | Volume: 6 | Issue: No issue available | Pages: No page available

10.1177/2050313x18786405 | PMID 30013790 Get It

Adverse drug reactions can be unpredictable. However, pharmacogenomic testing can help identify patients who may be more susceptible to the toxic effects of certain drugs. Genetic variations in the dihydropyrimidine dehydrogenase and thymidylate synthase genes have been shown to increase the risk of 5-fluorouracil toxicity. 5-Fluorouracil toxicity can be life threatening. Fortunately, there is treatment available for 5-fluorouracil toxicity, called uridine triacetate. Although, the indications for its use limit its administration to within 96 h of receiving 5-fluorouracil, we report a case of effective therapy in a patient started on uridine triacetate beyond the recommended 96 h, who was found to carry a thymidylate synthase gene variation but no dihydropyrimidine dehydrogenase mutations. This provides important implications for pharmacogenomic testing.
Management patterns of gastric polyps in the United States
Corral, Juan E. , Keihanian, Tara , Diaz, Liege I., Morgan, Douglas R. , Sussman, Daniel A.

Mayo Clinic

Frontline Gastroenterology | July 4, 2018 | Volume: 10 | Issue: 1 | Pages: 16-23

10.1136/flgastro-2017-100941 | PMID 30651953 Get It

Objective Recent guidelines on endoscopic sampling recommend complete gastric polyp removal for solitary fundic polyps >10 mm, hyperplastic polyps >5 mm and all adenomatous polyps. We aim to describe endoscopic approach to polyps in the time period prior to the American Society of Gastrointestinal Endoscopy (ASGE) guidelines and to identify opportunities for clinical practice improvements. Design Retrospective review of the Clinical Outcome Research Initiative (CORI) database, including all oesophagogastroduodenoscopies (OGDs). Reviewers grouped interventions during procedures based on instruments used for polyp sampling by forceps or snare polypectomy. Logistic regression estimated the effect of variables of interest on method of polypectomy. Results Of 783 037 OGDs reported in the CORI database, 25 670 (3.3%) described gastric polyps and met the inclusion criteria. Mean gastric polyp size was 6.5±4.9 mm, and 46.2% and 14.5% were located in the corpus and antrum, respectively. Polyps in the forceps group were smaller than polyps in the snare group (5.7±4.0 mm vs 9.3±6.4 mm, respectively, p<0.001). We identified 1056 polyps (41.3%) >10 mm that only underwent forceps biopsy. Forceps were used more frequently in the gastric fundus. Conclusions Snare polypectomy was underused in gastric polyps, per current ASGE guidelines. Anatomical location and endoscopic features of polyps were important predictors of the approach to gastric polypectomy.
Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series
Armour, Sarah, Armour, Trygve, Joppa, William R., Maltais, Simon, Nelson, James A. , Wittwer, Erica D.

Mayo Clinic

Anesthesia & Analgesia | July 4, 2018 | Volume: 129 | Issue: 1 | Pages: e1-e4

10.1213/ane.0000000000003648 | PMID 29979199 Get It

Hydroxocobalamin (vitamin B12a) is an emerging treatment for vasoplegic syndrome (VS) associated with cardiopulmonary bypass (CPB). Given its cost and scarcity, an institutional guideline for its use as a rescue treatment in cases of suspected VS was developed. Hemodynamic variables and vasopressor requirements were reviewed for a series of 24 post-CPB patients who received B12a. Favorable changes in hemodynamic parameters and vasopressor requirements were seen after B12a administration although guideline criteria for VS were inconsistently met. These findings support the continued study of B12a in patients with CPB-associated VS.
In Reply: Increased Body Mass Index Associated With Reduced Risk of Delayed Cerebral Ischemia and Subsequent Infarction After Aneurysmal Subarachnoid Hemorrhage
Rinaldo, Lorenzo , Rabinstein, Alejandro A. , Lanzino, Giuseppe

Mayo Clinic

Neurosurgery | July 4, 2018 | Volume: 83 | Issue: 5 | Pages: E220-E220

10.1093/neuros/nyy345 | PMID 30203019 Get It

SCN5A mutations in 442 neonates and children: genotype–phenotype correlation and identification of higher-risk subgroups
Baruteau, Alban‐Elouen , Kyndt, Florence , Behr, Elijah R. , Vink, Arja S. , Lachaud, Matthias , Joong, Anna , Horie, Minoru , Crotti, Lia , Bos, J. Martijn , Stephenson, Elizabeth A. , Wong, Leonie C.H., Abrams, Dominic J. , Davis, Andrew M. , Winbo, Annika , Sanatani, Shubhayan , Liberman, Leonardo , Kaski, Juan Pablo , Rudic, Boris , Kwok, Sit Yee, Rieubland, Claudine, Tfelt‐Hansen, Jacob , Hare, George F. Van , Guyomarc’h-Delasalle, Béatrice, Wijeyeratne, Yanushi D. , Gourraud, Jean‐Baptiste , Marec, Hervé Le , Ozawa, Junichi , Fressart, Véronique , Lupoglazoff, Jean‐Marc, Spazzolini, Carla , Aiba, Takeshi , Tester, David J. , Zahavich, Laura , Beauséjour-Ladouceur, Virginie, Jadhav, Mangesh P. , Skinner, Jonathan R. , Franciosi, Sonia , Abdelsayed, Mena , Ruben, Peter C. , Yung, Tak‐Cheung , Ackerman, Michael J. , Wilde, Arthur A.M. , Probst, Vincent , Bos, Johan M, Crotti, Lia , Horie, Minoru , Behr, Elijah Raphael , Probst, Vincent , Bos, Johan M , Tfelt-Hansen, Jacob , Davis, Andrew , Skinner, Jonathan R , Sanatani, Shubhayan , Abrams, Dominic J , Baruteau, Alban-Elouen , Schott, Jean‐Jacques , Denjoy, Isabelle , Shimizu, Wataru , Dubin, Anne M. , Blom, Nico A. , Dagradi, Federica , Aiba, Takeshi , Krahn, Andrew D. , Schwartz, Peter J. , Kaski, Juan P , Gourraud, Jean-Baptiste , Spazzolini, Carla

Mayo Clinic

European Heart Journal | July 3, 2018 | Volume: 39 | Issue: 31 | Pages: 2879-2887

10.1093/eurheartj/ehy412 | PMID 30059973 Get It

Letter: Impact of H3.3 K27M Mutation on Prognosis and Survival of Grade IV Spinal Cord Glioma on the Basis of New 2016 World Health Organization Classification of the Central Nervous System
Lu, Victor M. , Alvi, Mohammed Ali , Alvi, Mohammed A, Daniels, David J. , Alvi, Mohammed Ali

Mayo Clinic

Neurosurgery | July 3, 2018 | Volume: 83 | Issue: 4 | Pages: E193-E194

10.1093/neuros/nyy347 | PMID 30379319 Get It